^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    Modi-1

    i
    Associations
    News

    Trials

    Company:
    ISA Pharma, Scancell
    Drug class:
    Immunostimulant
    Related drugs:
    Associations
    News

    Trials

    Apply
    Modi-1 in Breast, Head and Neck, Ovarian, or Renal Cancer (ModiFY) (NCT05329532)
    Phase 1/2
    Scancell Ltd
    Recruiting
    Last update posted :
    11/21/2022
    Initiation :
    04/07/2022
    Primary completion :
    04/04/2026
    Completion :
    06/30/2026
    PD-L1
    |
    PD-L1 expression
    |
    Keytruda (pembrolizumab) • Modi-1